Page last updated: 2024-08-26

bosentan anhydrous and Respiratory Distress Syndrome

bosentan anhydrous has been researched along with Respiratory Distress Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fraidenburg, DR; Guo, Q; Huang, JA1
Guimarães, CL; Rae, GA; Trentin, PG1
Abdel Kafi, S; Bejjani, G; Biarent, D; Hubloue, I; Leeman, M; Mélot, C; Naeije, R1
Behrends, M; Beiderlinden, M; Peters, J1
Couture, R; Da-Silva, S; Guimarães, CL; Rae, GA1
Belvisi, MG; Birrell, MA; Foster, ML; Hele, DJ; Webber, SE1

Other Studies

6 other study(ies) available for bosentan anhydrous and Respiratory Distress Syndrome

ArticleYear
Bosentan as rescue treatment in refractory hypoxemia and pulmonary hypertension in a patient with ARDS and H7N9 influenza virus infection.
    Lung, 2014, Volume: 192, Issue:5

    Topics: Antihypertensive Agents; Antiviral Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Hypoxia; Influenza A Virus, H7N9 Subtype; Influenza, Human; Male; Middle Aged; Positive-Pressure Respiration; Respiratory Distress Syndrome; Sulfonamides; Treatment Outcome

2014
Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Acute Disease; Analysis of Variance; Animals; Atrasentan; Bosentan; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Evans Blue; Lung; Male; Mice; Mice, Inbred Strains; Neutrophil Infiltration; Oleic Acid; Pyrimidines; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Respiratory Distress Syndrome; Sulfonamides

2002
Endothelin receptor blockade in canine oleic acid-induced lung injury.
    Intensive care medicine, 2003, Volume: 29, Issue:6

    Topics: Animals; Antihypertensive Agents; Bosentan; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Infusions, Intravenous; Oleic Acid; Prospective Studies; Pulmonary Circulation; Pulmonary Gas Exchange; Pulmonary Wedge Pressure; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Respiratory Distress Syndrome; Sulfonamides; Vascular Resistance

2003
Combination of sildenafil and bosentan for nitric oxide withdrawal.
    European journal of anaesthesiology, 2005, Volume: 22, Issue:2

    Topics: Antihypertensive Agents; Bosentan; Extracorporeal Membrane Oxygenation; Female; Humans; Middle Aged; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Respiratory Distress Syndrome; Sildenafil Citrate; Substance Withdrawal Syndrome; Sulfonamides; Sulfones; Vasodilator Agents; Ventilator Weaning

2005
Mixed endothelin ET(A) and ET(B) antagonist bosentan inhibits oleic acid-induced lung plasma extravasation in mouse.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:5 Suppl 1

    Topics: Animals; Bosentan; Capillary Permeability; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Evans Blue; Male; Mice; Oleic Acid; Receptor, Endothelin A; Receptor, Endothelin B; Respiratory Distress Syndrome; Sulfonamides

2000
Effect of endothelin antagonists, including the novel ET(A) receptor antagonist LBL 031, on endothelin-1 and lipopolysaccharide-induced microvascular leakage in rat airways.
    British journal of pharmacology, 2000, Volume: 131, Issue:6

    Topics: Animals; Antihypertensive Agents; Bosentan; Capillary Permeability; Endothelin Receptor Antagonists; Endothelin-1; Humans; Infant, Newborn; Lipopolysaccharides; Male; Oligopeptides; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Respiratory Distress Syndrome; Sulfonamides

2000